Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2007 035 292.4 |
96 | EP file number | EAKZ | 07 86 8153.3 |
86 | WO file number | WAKZ | PCT/US2007/026522 |
97 | EP publication number | EPN | 2114458 |
87 | WO publication number | WPN | 2008082669 |
54 | Designation/title | TI | VON-WILLEBRAND-FAKTOR- UND FAKTOR-VIII-POLYMERKONJUGATE MIT LÖSBARER VERBINDUNG |
51 | IPC main class | ICM (ICMV) | A61K 47/50 (2017.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61P 7/00 (2006.01), C07K 14/755 (2006.01) |
22 | DE application date | DAT | Dec 27, 2007 |
96 | EP application date | EAT | Dec 27, 2007 |
86 | WO application date | WAT | Dec 27, 2007 |
43 | Date of first publication | OT | Jul 10, 2008 |
| Date of publication of grant | PET | Feb 26, 2014 |
71/73 | Applicant/owner | INH | Nektar Therapeutics, San Francisco, Calif., US; Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
72 | Inventor | IN | FANG, Zhihao, Madison, AL 35758, US; GRITSCH, Herbert, A-1140 Vienna, AT; BOSSARD, Mary, J., Madison, AL 35758, US; TURECEK, Peter, A-3400 Klosterneuburg, AT; STEPHENSON, Gayle, Decatur, AL 35601, US; SIEKMANN, Juergen, A-1210 Vienna, AT; VARADI, Katalin, A-1230 Vienna, AT; ZHANG, Ping, Madison, AL 35758, US; ZAPPE, Harold, Harvest, AL 35749, US; MITCHELL, Stacy, Madison, AL 35758, US; SCHEIFLINGER, Friedrich, A-1090 Vienna, AT |
| Address for service | | Weickmann & Weickmann Patent- und Rechtsanwälte PartmbB, 81635 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 877531 P Dec 27, 2006
|
| Due date | FT FG | Dec 31, 2025 Annual fee for the 19th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, PL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | AL, RS, HR, BA, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000002114458 Searchable text:
EP000002114458 Original document:
EP000002114458B1 Searchable text:
EP000002114458B1 Original document:
WO002008082669 Searchable text:
WO002008082669 |
43 | Date of first publication | EVT | Jul 10, 2008 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Nov 16, 2024 (Show all update days)(Hide all update days)- Nov 16, 2024
- Nov 15, 2023; Nov 15, 2022; Nov 16, 2021; Nov 4, 2021; Nov 17, 2020; Nov 21, 2019; Nov 22, 2018; Oct 29, 2018; Jan 17, 2018; Jan 10, 2018; Jan 12, 2017; Jan 5, 2017; Jan 20, 2016; Oct 27, 2015; Mar 12, 2015; Feb 5, 2015; Jan 22, 2015; Sep 4, 2014; Apr 12, 2014; Apr 11, 2014; Apr 10, 2014; Mar 2, 2014; Feb 27, 2014; Feb 13, 2013
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 10)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Nov 3, 2021 |
| Issue number | HN | 49 |
| Year | PJ | 2021 |
| Publication date | VT | Dec 9, 2021 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Nektar Therapeutics, San Francisco, Calif., US; Takeda Pharmaceutical Company Limited, Osaka-shi, JP |
71/73 | Previous applicant/owner | INHF | Baxter Healthcare SA, Glattpark, Opfikon, CH, Baxter International Inc., Deerfield, Ill., US, Nektar Therapeutics, San Francisco, Calif., US |
| Date of update of the procedure | REGT | Nov 16, 2021 |